CD8 antibody (CD8a Molecule) (FITC)

Details for Product anti-CD8A Antibody No. ABIN135119, Supplier: Log in to see
Antigen
  • cd8
  • LOC100136450
  • BB154331
  • Ly-2
  • Ly-35
  • Ly-B
  • Lyt-2
  • zgc:136643
  • CD8
  • Leu2
  • MAL
  • p32
  • RHACD8-4
  • CD8 antigen, alpha chain
  • CD8 antigen, alpha polypeptide
  • CD8 alpha
  • T-cell surface glycoprotein CD8 alpha chain-like
  • CD8a molecule
  • Cd8a
  • cd8
  • LOC100136450
  • LOC100387674
  • cd8a
  • CD8A
Alternatives
anti-Mouse (Murine) CD8 antibody for Biochemical Assay
Reactivity
Mouse (Murine)
598
489
127
92
43
26
19
13
13
13
12
12
9
4
2
1
1
Host
Rat
754
452
197
1
1
Clonality (Clone)
Monoclonal ()
Conjugate
This CD8 antibody is conjugated to FITC
148
143
90
55
45
36
36
33
29
27
24
23
23
23
22
22
20
18
18
18
14
13
11
11
11
10
9
7
7
7
5
4
4
4
4
4
4
4
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Application
Flow Cytometry (FACS), Immunohistochemistry (IHC)
1135
430
364
250
246
234
197
184
173
25
23
20
16
13
11
11
9
7
6
6
6
6
3
2
2
2
2
2
2
1
1
1
1
1
1
1
Options
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Clone 53-6-7
Isotype IgG2a
Characteristics The antibody detects: chain of the murine CD8 heterodimer, Mr 32-34 kDa
The 53-6.7 monoclonal antibody also blocks allogeneic help specific for class I MHC antigens and T cell responses to IL-2.
Alternative Name CD8a/Ly-2 (CD8A Antibody Abstract)
Background In the mouse, CD8 exists in two forms: (i) a CD8 heterodimer composed of an chain (CD8/Lyt-2) and a chain (CD8/Lyt-3), and (ii) a homodimer of two chains. The heterodimer is found on the surface of essentially all thymocytes and the suppressor/cytotoxic subpopulation of mature T lymphocytes. Subsets of intestinal intraepithelial lymphocytes express CD8 without CD8. It has been suggested that CD8+- T cells mature extrathymically, while development of the CD8++ population of T cells is thymus-dependent. CD8 acts as a coreceptor with MHC Class I-restricted T cell receptors in antigen recognition and positive selection of MHC class I-restricted CD8+ T cells. In vivo and in vitro treatment with the 53-6.7 monoclonal antibody effectively depletes CD8+ cells.
Pathways TCR Signaling
Application Notes Working Dilution:
FACS: 2 µg/10^6 cells
Representative data are included in this product insert.

Each laboratory should determine an optimum working titer for use in its particular application. Other applications have not been tested but use in such assays should not necessarily be excluded.
Comment

In vivo and in vitro depletion of CD8a+ cells

Sample Volume 1 mL
Restrictions For Research Use only
Buffer Product is supplied as 0.5 mg or 0.1 mg in 1.0 mL of PBS / NaN3.
Preservative Sodium azide
Precaution of Use WARNING: Reagents contain sodium azide. Sodium azide is very toxic if ingested or inhaled. Avoid contact with skin, eyes, or clothing. Wear eye or face protection when handling. If skin or eye contact occurs, wash with copious amounts of water. If ingested or inhaled, contact a physician immediately. Sodium azide yields toxic hydrazoic acid under acidic conditions. Dilute azide-containing compounds in running water before discarding to avoid accumulation of potentially explosive deposits in lead or copper plumbing.
Handling Advice Protect conjugated products from light.
Each reagent is stable for the period shown on the bottle label if stored as directed.
Storage 4 °C
Supplier Images
 image for anti-CD8 antibody (CD8a Molecule)  (FITC) (ABIN135119) anti-CD8a Molecule (CD8A) antibody (FITC)
Product cited in: Hintermann, Ehser, Christen: "The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice." in: Journal of visualized experiments : JoVE, Issue 60, 2012 (PubMed).

Safari, Dekker, Rijkers, Snippe: "Codelivery of adjuvants at the primary immunization site is essential for evoking a robust immune response to neoglycoconjugates." in: Vaccine, 2010 (PubMed).

Background publications Lefrançois: "Extrathymic differentiation of intraepithelial lymphocytes: generation of a separate and unequal T-cell repertoire?" in: Immunology today, Vol. 12, Issue 12, pp. 436-8, 1992 (PubMed).

Lefrancois: "Phenotypic complexity of intraepithelial lymphocytes of the small intestine." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 147, Issue 6, pp. 1746-51, 1991 (PubMed).

Takahasi, Kondou, Watanabe, Noro, Makiishi, Ishikawa: "[Investigation of etching and bonding on the inner surface of free enamel. SEM observation and thermal cycling test for pigment invasion]" in: Shika gakuho. Dental science reports, Vol. 89, Issue 3, pp. 663-8, 1990 (PubMed).

Ledbetter, Seaman: "The Lyt-2, Lyt-3 macromolecules: structural and functional studies." in: Immunological reviews, Vol. 68, pp. 197-218, 1983 (PubMed).

Ledbetter, Rouse, Micklem, Herzenberg: "T cell subsets defined by expression of Lyt-1,2,3 and Thy-1 antigens. Two-parameter immunofluorescence and cytotoxicity analysis with monoclonal antibodies modifies current views." in: The Journal of experimental medicine, Vol. 152, Issue 2, pp. 280-95, 1980 (PubMed).